Palisade Bio, Inc. (PALI)
1.24
+0.12
(+10.71%)
USD |
NASDAQ |
Nov 03, 16:00
1.24
0.00 (0.00%)
After-Hours: 16:24
Palisade Bio Price : 1.24 for Nov. 3, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 02, 2026 | 1.20 | 1.20 | 1.08 | 1.12 | 3.073M |
| Oct 30, 2026 | 1.18 | 1.20 | 1.115 | 1.16 | 3.091M |
| Oct 29, 2026 | 1.20 | 1.25 | 1.15 | 1.19 | 3.506M |
| Oct 28, 2026 | 1.22 | 1.22 | 1.10 | 1.19 | 15.12M |
| Oct 27, 2026 | 1.22 | 1.255 | 1.17 | 1.20 | 6.013M |
| Oct 26, 2026 | 1.33 | 1.35 | 1.21 | 1.23 | 1.704M |
| Oct 23, 2026 | 1.35 | 1.37 | 1.28 | 1.33 | 1.334M |
| Oct 22, 2026 | 1.38 | 1.41 | 1.349 | 1.35 | 1.114M |
| Oct 21, 2026 | 1.44 | 1.46 | 1.39 | 1.40 | 1.433M |
| Oct 20, 2026 | 1.39 | 1.48 | 1.335 | 1.43 | 2.823M |
| Oct 19, 2026 | 1.41 | 1.46 | 1.32 | 1.34 | 1.838M |
| Oct 16, 2026 | 1.55 | 1.56 | 1.40 | 1.41 | 3.890M |
| Oct 15, 2026 | 1.50 | 1.56 | 1.48 | 1.54 | 1.818M |
| Oct 14, 2026 | 1.45 | 1.51 | 1.38 | 1.48 | 4.167M |
| Oct 13, 2026 | 1.56 | 1.579 | 1.46 | 1.465 | 1.589M |
| Oct 12, 2026 | 1.53 | 1.63 | 1.51 | 1.59 | 1.572M |
| Oct 09, 2026 | 1.49 | 1.57 | 1.47 | 1.54 | 1.841M |
| Oct 08, 2026 | 1.47 | 1.48 | 1.38 | 1.45 | 2.086M |
| Oct 07, 2026 | 1.46 | 1.48 | 1.44 | 1.48 | 825232.0 |
| Oct 06, 2026 | 1.51 | 1.55 | 1.47 | 1.49 | 1.973M |
| Oct 05, 2026 | 1.44 | 1.48 | 1.41 | 1.46 | 1.601M |
| Oct 02, 2026 | 1.46 | 1.48 | 1.425 | 1.44 | 1.996M |
| Oct 01, 2026 | 1.39 | 1.46 | 1.37 | 1.43 | 2.645M |
| Sep 30, 2026 | 1.44 | 1.46 | 1.32 | 1.35 | 4.766M |
| Sep 29, 2026 | 1.54 | 1.549 | 1.42 | 1.45 | 2.165M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.57 |
| Alnylam Pharmaceuticals, Inc. | 159.85 |
| Anika Therapeutics, Inc. | 19.34 |
| Savara, Inc. | 4.745 |
| Vericel Corp. | 41.08 |
Price Related Metrics
| PS Ratio | 364.54 |
| Price to Book Value | 1.768 |
| Earnings Yield | -43.17% |
| Market Cap | 215.26M |